Osteoporotic fracture, diagnostic activity, and treatment in patients with gout
Arthritis Care & Research · 10 Aug 2026
† Impact is the editorial-priority score. All scores are out of 100. Clinical is a stored clinical-importance score from the earlier method; it has not been recalculated.
Why it matters
It highlights that gout patients, who are frequently exposed to glucocorticoids and have comorbid CKD, are being under-screened and undertreated for osteoporosis despite bearing a higher fracture burden, a gap relevant to any clinician managing bone health in this population.
The evidence
This retrospective cohort study used a US rheumatology registry linked to Medicare claims to compare gout patients with osteoarthritis (OA) and soft tissue rheumatism (STR) patients regarding osteoporosis screening, treatment, and fracture rates. Gout patients had higher rates of nonvertebral osteoporotic fracture than OA (incidence rate ratio 1.4, 95% CI 1.1-1.8) and STR (IRR 2.0, 95% CI 1.3-3.1) patients, despite having more risk factors like chronic kidney disease and higher glucocorticoid exposure, yet they were less likely to undergo DXA screening or receive bone-protective medications.
Nonvertebral osteoporotic fracture (all fractures during follow-up): Risk ratio 1.4 (95% CI 1.1 to 1.8; units not reported). Interpret in the study's stated comparison; this alone does not establish a treatment's causal effect.
Why this rigour score?
Registry cohort (adjusted)
Methods at a glance
Recorded assessment- Confounding adjustmentMultivariable regression
- Covariate balance confirmedNot met
- Outcome assessors blindedNot reported
- Comparable start of follow-upMet
- Adequate statistical powerNot applicable
- Prospective registrationNot met
Not reported does not mean not done. Checks have different weights; this is not a count of boxes ticked.
How to read this assessment
The recorded methods are shown alongside the published score. A verified point-by-point calculation is not available for this version of the appraisal.
Checklist from the stored appraisal. “Not met” describes the recorded criterion; it does not always produce a deduction. This overview supports reading the full study.
For journal club
1.Should routine gout management protocols incorporate mandatory DXA screening and fracture-risk assessment given the elevated fracture rates observed in this cohort?
2.How should glucocorticoid dosing and duration be balanced against osteoporosis risk when treating recurrent gout flares in patients with comorbid CKD?
Original publication title
Osteoporotic fracture, diagnostic activity, and treatment in patients with gout